| |
Centre for Policy on Ageing | |
 | |
|
Antidementia drugs
— prescription by level of cognitive impairment or by socio-economic group? | | Author(s) | Claudia Cooper, Martin Blanchard, Amber Selwood |
| Journal title | Aging & Mental Health, vol 14, no 1, January 2010 |
| Publisher | Taylor & Francis, January 2010 |
| Pages | pp 85-89 |
| Source | http://www.tandfonline.com |
| Keywords | Dementia ; Drugs ; Economic status [elderly] ; Mental disorder ; Cross sectional surveys ; London ; Essex. |
| Annotation | The authors aimed to investigate for the first time whether cholinesterase inhibitor prescription was associated with economic status in a population of people with dementia. 215 people with dementia were recruited, living independently, who were consecutively referred to five Community Mental Health Teams in London and Essex. The authors tested their hypothesis that home owners were more likely to be prescribed cholinesterase inhibitors than those who rented their accommodation. Results showed that people who owned their home were four times more likely to be prescribed cholinesterase inhibitors (OR 4.2, 1.8-9.8; p = 0.001). Younger age, fewer neuropsychiatric symptoms, having a dementia diagnosis for which cholinesterase inhibitors were recommended and longer time since diagnosis also predicted prescription, but severity of cognitive impairment did not. Despite high-profile guidelines that NHS cholinesterase prescribing should be restricted to people with moderate dementia, being a home owner was a strong predictor of prescription, while dementia severity was not. It is recommended that health services should be audited to ensure that access to treatment increases in those who are socioeconomically disadvantaged. (KJ/RH). |
| Accession Number | CPA-100426205 A |
| Classmark | EA: LLD: F:W: E: 3KB: 82L: 8ES |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|